Abivax - ADR (ABVX) Live Stock Price, Forecast & News

Abivax - ADR
ABVX
(Nasdaq - US)
N/A
13.94
-0.21 (-1.48%)
in:usd•As of: May 10, 2024 15:59 UTC -4
Open
14.26
High
14.27
Low
13.94

Stats

Prev. Close

14.15

Open

14.26

Day's Range

13.94 - 14.27

52 Week Range

8.00 - 17.02

YTD Change

30.28%

1 Year Change

N/A

Market Cap

877.24M

P/E Ratio

N/A

Volume

810.00

Beta

N/A

Sector

Health Technology

Industry

Pharmaceuticals Other

Economic CalendarAll Events

Time zone: GMT

Friday, May 10th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:00	USD	Michigan Consumer Sentiment PrelMay	High	67.4	76	77.2
16:45	USD	Fed Goolsbee Speech	Medium
17:30	USD	Fed Barr Speech	Medium
18:00	USD	Monthly Budget StatementApr	Medium	$210B	$244.5B	$-236B

Monday, May 13th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:00	USD	Fed Mester Speech	Medium
13:00	USD	Fed Jefferson Speech	Medium

Tuesday, May 14th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Core PPI MoMApr	Medium		0.2%	0.2%

Latest News

Seeking AlphaApr 8, 2024

ABIVAX Société Anonyme (AAVXF) Q4 2023 Earnings Call Transcript

ABVX-1.48%

Seeking AlphaOct 21, 2023

U.S. IPO Weekly Recap: Big Launches And New Filings Keep The IPO Market Moving

ABVX-1.48%

Market WatchOct 19, 2023

Abivax increases size of Nasdaq uplisting deal

ABVX-1.48%

Seeking AlphaOct 18, 2023

Abivax Readies $250 Million U.S. IPO For Drug Pipeline

ABVX-1.48%

Seeking AlphaOct 3, 2023

Abivax SA Starts U.S. IPO Process

ABVX-1.48%

Data Vendor: Xignite Logo

Stocks

Abivax - ADR

ABIVAX Société Anonyme (AAVXF) Q4 2023 Earnings Call Transcript

U.S. IPO Weekly Recap: Big Launches And New Filings Keep The IPO Market Moving

Abivax increases size of Nasdaq uplisting deal

Abivax Readies $250 Million U.S. IPO For Drug Pipeline

Abivax SA Starts U.S. IPO Process

Trade With A Regulated Broker